An analysis of radiotherapy in the management of 104 patients with parotid carcinoma.
A retrospective analysis was made of 104 patients with parotid carcinoma treated with radical radiotherapy between 1977 and 1986. Eighty-seven patients received postoperative radiotherapy and 17 had radiotherapy alone. The 5- and 10-year survival figures, corrected for intercurrent deaths, were 60% and 49% respectively, with primary control rates of 68% and 58%. Local control was significantly better for patients initially presenting with T1/T2 disease, but local relapse still occurred in 23% of these patients. Of 13 patients with acinic cell tumours, four developed local recurrence and a further two had metastatic disease. These patterns of relapse suggest that patients with parotid carcinoma should receive postoperative radiotherapy irrespective of disease stage or histological type.
Sykes
A J
AJ
Christie Hospital, Manchester, UK.
Logue
J P
JP
Slevin
N J
NJ
Gupta
N K
NK
D000293:Adolescent; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010307:Parotid Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D011184:Postoperative Period; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate